Patient derived xenograft

Patient-derived xenografts and organoids model therapy response in prostate cancer

This proof-of-principle study provides a preclinical tool to screen drug responses to standard-of-care and newly identified, repurposed compounds.

Patient-derived xenografts and organoids model therapy response in prostate cancer

This proof-of-principle study provides a preclinical tool to screen drug responses to standard-of-care and newly identified, repurposed compounds.